Aside from filaggrin, loricrin and involucrin are also downregulated by IL-4 and IL-13 in lesional and non-lesional atopic dermatitis skin, contributing to a defective skin barrier that allows penetration of bacteria and allergens into the skin, leading to infections and allergen sensitization [11]. Here, IL4 is linked to atopic eczema.